gallic acid has been researched along with Parkinsonian Disorders in 3 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was evaluation the effect of Gallic acid on movement disorders and pallidal electrical power in animal model of Parkinson's Disease (PD)." | 3.77 | Motor disorders and impaired electrical power of pallidal EEG improved by gallic acid in animal model of Parkinson's disease. ( Farbood, Y; Mansouri, SM; Sameri, MJ; Sarkaki, A, 2011) |
| "Syringic acid (SA) is a polyphenolic compound which has antioxidant and anti-inflammatory properties." | 1.62 | Protective mechanism of Syringic acid in an experimental model of Parkinson's disease. ( Afşar, E; Ağar, A; Aslan, M; Bülbül, M; Güzelad, Ö; Öğüt, E; Özkan, A; Parlak, H; Sinen, O; Yıldırım, FB, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Güzelad, Ö | 1 |
| Özkan, A | 1 |
| Parlak, H | 1 |
| Sinen, O | 1 |
| Afşar, E | 1 |
| Öğüt, E | 1 |
| Yıldırım, FB | 1 |
| Bülbül, M | 1 |
| Ağar, A | 1 |
| Aslan, M | 1 |
| Shi, XR | 1 |
| Hong, ZY | 1 |
| Liu, HR | 1 |
| Zhang, YC | 1 |
| Zhu, YZ | 1 |
| Sameri, MJ | 1 |
| Sarkaki, A | 1 |
| Farbood, Y | 1 |
| Mansouri, SM | 1 |
3 other studies available for gallic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Protective mechanism of Syringic acid in an experimental model of Parkinson's disease.
Topics: Animals; Dopamine; Dopaminergic Neurons; Gallic Acid; Male; Motor Activity; Neuroprotective Agents; | 2021 |
Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Topics: Animals; Behavior, Animal; Cell Line, Tumor; Cell Survival; Gallic Acid; Humans; Leonurus; Male; Ner | 2011 |
Motor disorders and impaired electrical power of pallidal EEG improved by gallic acid in animal model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Antioxidants; Disease Models, Animal; Electroencephalography; Gallic Aci | 2011 |